| Journal of Otolaryngology - Head & Neck Surgery | |
| Cuproptosis-related gene subtypes predict prognosis in patients with head and neck squamous cell carcinoma | |
| Original Research Article | |
| Chi Wang1  Yu Zhou2  | |
| [1] Department of Oral and Maxillofacial Surgery, School & Hospital of Stomatology, Wenzhou Medical University, 325000, Wenzhou, Zhejiang, China;Department of Orthodontics, School & Hospital of Stomatology, Wenzhou Medical University, 373 West College Road, 325000, Wenzhou, Zhejiang, China; | |
| 关键词: Head and neck squamous cell carcinoma; Cuproptosis; Genes; Prognosis; Survival model; | |
| DOI : 10.1186/s40463-023-00655-4 | |
| received in 2022-12-30, accepted in 2023-07-23, 发布年份 2023 | |
| 来源: Springer | |
PDF
|
|
【 摘 要 】
BackgroundHead and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. A novel form of copper-dependent and reactive oxygen species (ROS)-dependent cell death, cuproptosis, has been described in many cancers. The roles and potential mechanisms of cuproptosis-related genes (CRGs) are still unclear in HNSCC.MethodWe downloaded TCGA datasets of HNSCC genomic mutations and clinic data from The Cancer Genome Atlas. Based on the Cuproptosis-related differentially expressed genes in HNSCC, we constructed a prognostic signature.ResultsEight CRGs have been identified as associated with the prognosis of HNSCC. According to Kaplan–Meier analyses, HNSCC with a high Risk Score had a poor prognosis. Furthermore, the AUC of the Risk Score for the 1-, 3-, and 5- year overall survival was respectively, 0.70, 0.71, and 0.68. TCGA data revealed that T cell functions, such as HLA, cytolytic activity, inflammation regulation, co-inhibition, and co-stimulation, differed significantly between members of the low and high groups. The immune checkpoint genes PD-L1, PD-L1, and CTLA-4 were also expressed differently in the two risk groups.ConclusionsA CRG signature was defined that is associated with the prognosis of patients with HNSCC.Graphical abstract
【 授权许可】
CC BY
© Canadian Society Of Otolaryngology-Head & Neck Surgery 2023
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202310112070655ZK.pdf | 9573KB | ||
| 1962KB | Image | ||
| Fig. 1 | 457KB | Image | |
| Fig. 2 | 400KB | Image | |
| Fig. 2 | 55KB | Image | |
| 13690_2023_1170_Article_IEq140.gif | 1KB | Image | |
| 13690_2023_1170_Article_IEq142.gif | 1KB | Image | |
| Fig. 2 | 371KB | Image | |
| MediaObjects/41408_2023_922_MOESM1_ESM.pptx | 49KB | Other | |
| MediaObjects/12888_2023_5158_MOESM1_ESM.docx | 28KB | Other | |
| Fig. 9 | 439KB | Image | |
| MediaObjects/41408_2023_922_MOESM4_ESM.docx | 12KB | Other | |
| 13690_2023_1170_Article_IEq38.gif | 1KB | Image | |
| Fig. 12 | 827KB | Image | |
| MediaObjects/12888_2023_5155_MOESM4_ESM.pptx | 72KB | Other | |
| Fig. 5 | 2762KB | Image | |
| MediaObjects/40463_2023_655_MOESM1_ESM.zip | 272KB | Package |
【 图 表 】
Fig. 5
Fig. 12
13690_2023_1170_Article_IEq38.gif
Fig. 9
Fig. 2
13690_2023_1170_Article_IEq142.gif
13690_2023_1170_Article_IEq140.gif
Fig. 2
Fig. 2
Fig. 1
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]
- [39]
- [40]
- [41]
- [42]
- [43]
- [44]
- [45]
- [46]
- [47]
- [48]
- [49]
PDF